EMEA (Europe, Middle East and Africa) Metabolomics Market Report 2017

August 2017 | 113 pages | ID: E61A56B06C2EN
QYResearch

Abstracts

In this report, the EMEA Metabolomics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Metabolomics for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Metabolomics market competition by top manufacturers/players, with Metabolomics sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Shimadzu Corporation
• Bio-Rad Laboratories
• Bruker Corporation
• Danaher Corporation
• Human Metabolome Technologies
• LECO Corporation
• Agilent Technologies
• Biocrates Life Sciences AG
• Thermo Fisher Scientific
• Waters Corporation
• Metabolon

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Metabolomic Instruments
• Metabolomic Bioinformatics Tools And Services

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Metabolomics for each application, including

• Cardiovascular Disorders
• Inborn Errors Of Metabolism
• Cancer
• Neurological Disorders
• Others

Contents

EMEA (Europe, Middle East and Africa) Metabolomics Market Report 2017

1 METABOLOMICS OVERVIEW

1.1 Product Overview and Scope of Metabolomics
1.2 Classification of Metabolomics
  1.2.1 EMEA Metabolomics Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Metabolomics Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Metabolomic Instruments
  1.2.4 Metabolomic Bioinformatics Tools And Services
1.3 EMEA Metabolomics Market by Application/End Users
  1.3.1 EMEA Metabolomics Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Cardiovascular Disorders
  1.3.3 Inborn Errors Of Metabolism
  1.3.4 Cancer
  1.3.5 Neurological Disorders
  1.3.6 Others
1.4 EMEA Metabolomics Market by Region
  1.4.1 EMEA Metabolomics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Metabolomics (2012-2022)
  1.5.1 EMEA Metabolomics Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Metabolomics Revenue and Growth Rate (2012-2022)

2 EMEA METABOLOMICS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Metabolomics Market Competition by Players/Manufacturers
  2.1.1 EMEA Metabolomics Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Metabolomics Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Metabolomics Sale Price by Players (2012-2017)
2.2 EMEA Metabolomics (Volume and Value) by Type/Product Category
  2.2.1 EMEA Metabolomics Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Metabolomics Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Metabolomics Sale Price by Type (2012-2017)
2.3 EMEA Metabolomics (Volume) by Application
2.4 EMEA Metabolomics (Volume and Value) by Region
  2.4.1 EMEA Metabolomics Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Metabolomics Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Metabolomics Sales Price by Region (2012-2017)

3 EUROPE METABOLOMICS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Metabolomics Sales and Value (2012-2017)
  3.1.1 Europe Metabolomics Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Metabolomics Revenue and Growth Rate (2012-2017)
3.2 Europe Metabolomics Sales and Market Share by Type
3.3 Europe Metabolomics Sales and Market Share by Application
3.4 Europe Metabolomics Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Metabolomics Sales Volume by Countries (2012-2017)
  3.4.2 Europe Metabolomics Revenue by Countries (2012-2017)
  3.4.3 Germany Metabolomics Sales and Growth Rate (2012-2017)
  3.4.4 France Metabolomics Sales and Growth Rate (2012-2017)
  3.4.5 UK Metabolomics Sales and Growth Rate (2012-2017)
  3.4.6 Russia Metabolomics Sales and Growth Rate (2012-2017)
  3.4.7 Italy Metabolomics Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Metabolomics Sales and Growth Rate (2012-2017)

4 MIDDLE EAST METABOLOMICS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Metabolomics Sales and Value (2012-2017)
  4.1.1 Middle East Metabolomics Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Metabolomics Revenue and Growth Rate (2012-2017)
4.2 Middle East Metabolomics Sales and Market Share by Type
4.3 Middle East Metabolomics Sales and Market Share by Application
4.4 Middle East Metabolomics Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Metabolomics Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Metabolomics Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Metabolomics Sales and Growth Rate (2012-2017)
  4.4.4 Israel Metabolomics Sales and Growth Rate (2012-2017)
  4.4.5 UAE Metabolomics Sales and Growth Rate (2012-2017)
  4.4.6 Iran Metabolomics Sales and Growth Rate (2012-2017)

5 AFRICA METABOLOMICS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Metabolomics Sales and Value (2012-2017)
  5.1.1 Africa Metabolomics Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Metabolomics Revenue and Growth Rate (2012-2017)
5.2 Africa Metabolomics Sales and Market Share by Type
5.3 Africa Metabolomics Sales and Market Share by Application
5.4 Africa Metabolomics Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Metabolomics Sales Volume by Countries (2012-2017)
  5.4.2 Africa Metabolomics Revenue by Countries (2012-2017)
  5.4.3 South Africa Metabolomics Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Metabolomics Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Metabolomics Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Metabolomics Sales and Growth Rate (2012-2017)

6 EMEA METABOLOMICS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Shimadzu Corporation
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Metabolomics Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Shimadzu Corporation Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bio-Rad Laboratories
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Metabolomics Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bio-Rad Laboratories Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bruker Corporation
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Metabolomics Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bruker Corporation Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Danaher Corporation
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Metabolomics Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Danaher Corporation Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Human Metabolome Technologies
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Metabolomics Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Human Metabolome Technologies Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 LECO Corporation
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Metabolomics Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 LECO Corporation Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Agilent Technologies
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Metabolomics Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Agilent Technologies Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Biocrates Life Sciences AG
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Metabolomics Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Biocrates Life Sciences AG Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Thermo Fisher Scientific
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Metabolomics Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Thermo Fisher Scientific Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Waters Corporation
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Metabolomics Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Waters Corporation Metabolomics Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Metabolon

7 METABOLOMICS MANUFACTURING COST ANALYSIS

7.1 Metabolomics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Metabolomics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Metabolomics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Metabolomics Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA METABOLOMICS MARKET FORECAST (2017-2022)

11.1 EMEA Metabolomics Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Metabolomics Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Metabolomics Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Metabolomics Price and Trend Forecast (2017-2022)
11.2 EMEA Metabolomics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Metabolomics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Metabolomics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Metabolomics Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Metabolomics Sales Forecast by Type (2017-2022)
11.7 EMEA Metabolomics Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Metabolomics
Figure EMEA Metabolomics Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Metabolomics Sales Volume Market Share by Type (Product Category) in 2016
Figure Metabolomic Instruments Product Picture
Figure Metabolomic Bioinformatics Tools And Services Product Picture
Figure EMEA Metabolomics Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Metabolomics by Application in 2016
Figure Cardiovascular Disorders Examples
Figure Inborn Errors Of Metabolism Examples
Figure Cancer Examples
Figure Neurological Disorders Examples
Figure Others Examples
Figure EMEA Metabolomics Market Size (Million USD) by Region (2012-2022)
Figure Europe Metabolomics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Metabolomics Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Metabolomics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Metabolomics Revenue (Million USD) Status and Forecast by Countries
Figure Africa Metabolomics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Metabolomics Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Metabolomics Sales Volume and Growth Rate (2012-2022)
Figure EMEA Metabolomics Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Metabolomics Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Metabolomics Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Metabolomics Sales Share by Players (2012-2017)
Figure 2016 Metabolomics Sales Share by Players
Figure 2017 Metabolomics Sales Share by Players
Figure EMEA Metabolomics Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Metabolomics Revenue (Million USD) by Players (2012-2017)
Table EMEA Metabolomics Revenue Share by Players (2012-2017)
Table 2016 EMEA Metabolomics Revenue Share by Players
Table 2017 EMEA Metabolomics Revenue Share by Players
Table EMEA Metabolomics Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Metabolomics Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Metabolomics Sales Share by Type (2012-2017)
Figure Sales Market Share of Metabolomics by Type (2012-2017)
Figure EMEA Metabolomics Sales Market Share by Type (2012-2017)
Table EMEA Metabolomics Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Metabolomics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Metabolomics by Type in 2016
Table EMEA Metabolomics Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Metabolomics Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Metabolomics Sales Share by Application (2012-2017)
Figure Sales Market Share of Metabolomics by Application (2012-2017)
Figure EMEA Metabolomics Sales Market Share by Application in 2016
Table EMEA Metabolomics Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Metabolomics Sales Share by Region (2012-2017)
Figure Sales Market Share of Metabolomics by Region (2012-2017)
Figure EMEA Metabolomics Sales Market Share in 2016
Table EMEA Metabolomics Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Metabolomics Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Metabolomics by Region (2012-2017)
Figure EMEA Metabolomics Revenue Market Share Regions in 2016
Table EMEA Metabolomics Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Metabolomics Revenue and Growth Rate (2012-2017)
Table Europe Metabolomics Sales (K Units) by Type (2012-2017)
Table Europe Metabolomics Market Share by Type (2012-2017)
Figure Europe Metabolomics Market Share by Type in 2016
Table Europe Metabolomics Sales (K Units) by Application (2012-2017)
Table Europe Metabolomics Market Share by Application (2012-2017)
Figure Europe Metabolomics Market Share by Application in 2016
Table Europe Metabolomics Sales (K Units) by Countries (2012-2017)
Table Europe Metabolomics Sales Market Share by Countries (2012-2017)
Figure Europe Metabolomics Sales Market Share by Countries (2012-2017)
Figure Europe Metabolomics Sales Market Share by Countries in 2016
Table Europe Metabolomics Revenue (Million USD) by Countries (2012-2017)
Table Europe Metabolomics Revenue Market Share by Countries (2012-2017)
Figure Europe Metabolomics Revenue Market Share by Countries (2012-2017)
Figure Europe Metabolomics Revenue Market Share by Countries in 2016
Figure Germany Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure France Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure UK Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Metabolomics Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Metabolomics Sales (K Units) by Type (2012-2017)
Table Middle East Metabolomics Market Share by Type (2012-2017)
Figure Middle East Metabolomics Market Share by Type (2012-2017)
Table Middle East Metabolomics Sales (K Units) by Applications (2012-2017)
Table Middle East Metabolomics Market Share by Applications (2012-2017)
Figure Middle East Metabolomics Sales Market Share by Application in 2016
Table Middle East Metabolomics Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Metabolomics Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Metabolomics Sales Volume Market Share by Countries in 2016
Table Middle East Metabolomics Revenue (Million USD) by Countries (2012-2017)
Table Middle East Metabolomics Revenue Market Share by Countries (2012-2017)
Figure Middle East Metabolomics Revenue Market Share by Countries (2012-2017)
Figure Middle East Metabolomics Revenue Market Share by Countries in 2016
Figure Saudi Arabia Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Metabolomics Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Metabolomics Sales (K Units) by Type (2012-2017)
Table Africa Metabolomics Sales Market Share by Type (2012-2017)
Figure Africa Metabolomics Sales Market Share by Type (2012-2017)
Figure Africa Metabolomics Sales Market Share by Type in 2016
Table Africa Metabolomics Sales (K Units) by Application (2012-2017)
Table Africa Metabolomics Sales Market Share by Application (2012-2017)
Figure Africa Metabolomics Sales Market Share by Application (2012-2017)
Table Africa Metabolomics Sales Volume (K Units) by Countries (2012-2017)
Table Africa Metabolomics Sales Market Share by Countries (2012-2017)
Figure Africa Metabolomics Sales Market Share by Countries (2012-2017)
Figure Africa Metabolomics Sales Market Share by Countries in 2016
Table Africa Metabolomics Revenue (Million USD) by Countries (2012-2017)
Table Africa Metabolomics Revenue Market Share by Countries (2012-2017)
Figure Africa Metabolomics Revenue Market Share by Countries (2012-2017)
Figure Africa Metabolomics Revenue Market Share by Countries in 2016
Figure South Africa Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Table Shimadzu Corporation Metabolomics Basic Information List
Table Shimadzu Corporation Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shimadzu Corporation Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Shimadzu Corporation Metabolomics Sales Market Share in EMEA (2012-2017)
Figure Shimadzu Corporation Metabolomics Revenue Market Share in EMEA (2012-2017)
Table Bio-Rad Laboratories Metabolomics Basic Information List
Table Bio-Rad Laboratories Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bio-Rad Laboratories Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Bio-Rad Laboratories Metabolomics Sales Market Share in EMEA (2012-2017)
Figure Bio-Rad Laboratories Metabolomics Revenue Market Share in EMEA (2012-2017)
Table Bruker Corporation Metabolomics Basic Information List
Table Bruker Corporation Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bruker Corporation Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Bruker Corporation Metabolomics Sales Market Share in EMEA (2012-2017)
Figure Bruker Corporation Metabolomics Revenue Market Share in EMEA (2012-2017)
Table Danaher Corporation Metabolomics Basic Information List
Table Danaher Corporation Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Danaher Corporation Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Danaher Corporation Metabolomics Sales Market Share in EMEA (2012-2017)
Figure Danaher Corporation Metabolomics Revenue Market Share in EMEA (2012-2017)
Table Human Metabolome Technologies Metabolomics Basic Information List
Table Human Metabolome Technologies Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Human Metabolome Technologies Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Human Metabolome Technologies Metabolomics Sales Market Share in EMEA (2012-2017)
Figure Human Metabolome Technologies Metabolomics Revenue Market Share in EMEA (2012-2017)
Table LECO Corporation Metabolomics Basic Information List
Table LECO Corporation Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure LECO Corporation Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure LECO Corporation Metabolomics Sales Market Share in EMEA (2012-2017)
Figure LECO Corporation Metabolomics Revenue Market Share in EMEA (2012-2017)
Table Agilent Technologies Metabolomics Basic Information List
Table Agilent Technologies Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Agilent Technologies Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Agilent Technologies Metabolomics Sales Market Share in EMEA (2012-2017)
Figure Agilent Technologies Metabolomics Revenue Market Share in EMEA (2012-2017)
Table Biocrates Life Sciences AG Metabolomics Basic Information List
Table Biocrates Life Sciences AG Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biocrates Life Sciences AG Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Biocrates Life Sciences AG Metabolomics Sales Market Share in EMEA (2012-2017)
Figure Biocrates Life Sciences AG Metabolomics Revenue Market Share in EMEA (2012-2017)
Table Thermo Fisher Scientific Metabolomics Basic Information List
Table Thermo Fisher Scientific Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Metabolomics Sales Market Share in EMEA (2012-2017)
Figure Thermo Fisher Scientific Metabolomics Revenue Market Share in EMEA (2012-2017)
Table Waters Corporation Metabolomics Basic Information List
Table Waters Corporation Metabolomics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Waters Corporation Metabolomics Sales (K Units) and Growth Rate (2012-2017)
Figure Waters Corporation Metabolomics Sales Market Share in EMEA (2012-2017)
Figure Waters Corporation Metabolomics Revenue Market Share in EMEA (2012-2017)
Table Metabolon Metabolomics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Metabolomics
Figure Manufacturing Process Analysis of Metabolomics
Figure Metabolomics Industrial Chain Analysis
Table Raw Materials Sources of Metabolomics Major Manufacturers in 2016
Table Major Buyers of Metabolomics
Table Distributors/Traders List
Figure EMEA Metabolomics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Metabolomics Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Metabolomics Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Metabolomics Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Metabolomics Sales Market Share Forecast by Region (2017-2022)
Table EMEA Metabolomics Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Metabolomics Revenue Market Share Forecast by Region (2017-2022)
Table Europe Metabolomics Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Metabolomics Sales Market Share Forecast by Countries (2017-2022)
Table Europe Metabolomics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Metabolomics Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Metabolomics Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Metabolomics Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Metabolomics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Metabolomics Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Metabolomics Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Metabolomics Sales Market Share Forecast by Countries (2017-2022)
Table Africa Metabolomics Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Metabolomics Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Metabolomics Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Metabolomics Sales Market Share Forecast by Type (2017-2022)
Table EMEA Metabolomics Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Metabolomics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources